Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUVA vs PUVA + IFN Alpha 2a in Mycosis Fungoides
NCT00630903Phase 4Terminated
- Sponsor
- Madrilenian Group of Cutaneous Lymphomas
- Start
- Jan 2000
- Primary completion
- Jan 2003
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa-2a in mycosis fungoides (MF), sponsored by Madrilenian Group of Cutaneous Lymphomas. Started Jan 2000; status: terminated.
02
Drugs
interferon alfa-2a
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT00630903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630903.